
Biovica International Investor Relations Material
Latest events

Q3 2025
Biovica International
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Biovica International
Access all reports
Biovica International AB, a biotechnology company, develops and commercializes blood-based biomarker assays that enhance the monitoring of cancer therapies and predict patient outcome. The company's focus is on prediction of treatment efficacy and prognosis, thereby providing physicians with objective decision-making tools that enable informed treatment choice. The company is based in Uppsala, Sweden.
Key slides for Biovica International


Q1 2025
Biovica International


Q1 2025
Biovica International
Latest articles
)
James Quincey: Coca-Cola Chairman and CEO
James Quincey has dedicated nearly three decades to The Coca-Cola Company, rising through the ranks to become CEO and Chairman of the company.
11 Mar 2025
)
PepsiCo: From Pepsi and Gatorade to Doritos and Lay's
PepsiCo has grown from a soda company into a global leader in food and beverages, with a portfolio of over 200 brands, including Pepsi, Lay's, and Gatorade.
11 Mar 2025
)
Bob Iger: Disney's Visionary CEO
Bob Iger is a legend in the entertainment industry, known for his visionary leadership and as one of the most influential CEOs in Disney's history.
10 Mar 2025
Ticker symbol
BIOVIC
Country
🇸🇪 Sweden